• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Long-term prognostic factors in Parkinson's disease (author's transl)].

作者信息

Guillard A, Chastang C

出版信息

Rev Neurol (Paris). 1978 May;134(5):341-54.

PMID:725403
Abstract

Acturial methods are used to study the correlation between the initial condition and early therapeutic results, and the present condition of 164 parkinsonian patients treated with L. dopa for 4 to 8 years. There is an ineluctable deterioration in motility. There is a lower risk in patients who are autonomous and only slightly akinetic at the beginning of treatment. Intellectual deterioration is seen in some patients only. The risk factors are: males, the clinical forms of Parkinson's disease in which tremor is not predominant, onset of the disease before 60 years of age, and depression and transitory psychotic disorders during the first year of treatment. This deterioration appears 3 to 5 years after starting dopatherapy, which could be the cause. Life expectancy is still reduced by the disease at the present time. It is longer in patients in whom the disease started with isolated tremors, absence of Babinski's sign, and no loss of autonomy, and those in whom a good initial therapeutic result was obtained.

摘要

相似文献

1
[Long-term prognostic factors in Parkinson's disease (author's transl)].
Rev Neurol (Paris). 1978 May;134(5):341-54.
2
[Long-term study of 416 cases of Parkinson disease. Prognostic factors and therapeutic implications].[416例帕金森病的长期研究。预后因素及治疗意义]
Rev Neurol (Paris). 1986;142(3):207-14.
3
Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.帕金森病丘脑底核刺激的预后因素:短期与长期效果的比较研究
Stereotact Funct Neurosurg. 2009;87(4):241-8. doi: 10.1159/000225977. Epub 2009 Jun 26.
4
Treatment of Parkinson's disease: levodopa as the first choice.帕金森病的治疗:左旋多巴为首选。
J Neurol. 2002 Sep;249 Suppl 2:II19-24. doi: 10.1007/s00415-002-1204-4.
5
Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.急性左旋多巴激发试验对持续长期左旋多巴反应进行临床预测的准确性作为特发性帕金森病诊断的主要标准。
Mov Disord. 2002 Jul;17(4):795-8. doi: 10.1002/mds.10123.
6
Long-term follow-up of early dopa treatment in Parkinson's disease.帕金森病早期多巴治疗的长期随访
Ann Neurol. 1986 Apr;19(4):365-72. doi: 10.1002/ana.410190410.
7
Young onset Parkinson's disease.早发型帕金森病
Mov Disord. 1987;2(2):73-91. doi: 10.1002/mds.870020201.
8
The impact of treatment with levodopa on Parkinson's disease.左旋多巴治疗对帕金森病的影响。
Q J Med. 1980;49(195):283-93.
9
Individual manifestations of Parkinson's disease after ten or more years of levodopa.左旋多巴治疗十年或更长时间后帕金森病的个体表现。
Mov Disord. 1986;1(3):187-92. doi: 10.1002/mds.870010304.
10
Evaluation of chronic levodopa therapy in Parkinson's disease.
J Neural Transm Suppl. 1986;22:201-7.

引用本文的文献

1
The role of the cerebellum in the pathophysiology of Parkinson's disease.小脑在帕金森病病理生理学中的作用。
Can J Neurol Sci. 2013 May;40(3):299-306. doi: 10.1017/s0317167100014232.
2
Morphological differences in Parkinson's disease with and without rest tremor.伴有和不伴有静止性震颤的帕金森病的形态学差异。
J Neurol. 2009 Feb;256(2):256-63. doi: 10.1007/s00415-009-0092-2. Epub 2009 Feb 4.
3
Prognostic implications of the motor symptoms of Parkinson's disease with respect to clinical, computertomographic and psychometric parameters.
帕金森病运动症状对临床、计算机断层扫描及心理测量参数的预后影响。
J Neural Transm. 1986;67(1-2):1-14. doi: 10.1007/BF01243355.
4
Cerebral atrophy and long-term response to levodopa in Parkinson's disease.帕金森病中的脑萎缩及对左旋多巴的长期反应
J Neurol. 1979;222(1):37-43. doi: 10.1007/BF00313265.